A three‐year double‐blind placebo‐controlled study with specific oral immunotherapy to Dermatophagoides: evidence of safety and efficacy in paediatric patients
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Summary: Very few double‐blind trials of oral immunotherapy have been reported. The majority of these have been performed with pollen extracts and the results have often been equivocal. The major weaknesses of these studies have been the short periods of the trials, the low doses of allergen employed and inadequate evaluation of efficacy. The present study has involved a placebo‐controlled double‐blind trial of oral immunotherapy for three years with Dermatophagoides pteronysstnus at relatively high doses in 18 paediatric patients. Throughout the trial clinical parameters (symptom and medication scores) and immunological parameters (specific IgE, IgG1 and IgG4 levels) were monitored in order to assess the safely and efficacy of the treatment. The treatment was well tolerated by all patients and no side‐effects were experienced. Clinical improvement was evident after the second year of therapy and this was confirmed by a significant reduction in conjunctiva! reactivity assessed by a specific conjunctival provocation lest. In addition, there were significant changes in the immunological parameters with a reduction in specific IgE and increased levels of IgG4 and IgGI, results in keeping with previous studies of oral and subcutaneous immunotherapy. Although the results do not provide an explanation of the basis of successful oral immunotherapy, they clearly demonstrate the efficacy and safety of the treatment and suggest that it may be a useful and more acceptable alternative for patients than the traditional subcutaneous immunotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oral immunotherapy in birch pollen hay fever
Taudorf, E., Laursen, L. C., Lanner, Å., Björksten, B., Dreborg, S., Søborg, M., & Weeke, B. (1987) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(87)90124-2 · Cited by 129
Cited by
Allergic Rhinitis and Its Impact on Asthma
Bousquet, J., van Cauwenberge, P., & Khaltaev, N. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.118891 · Cited by 3,588
Injection allergen immunotherapy for asthma
Abramson, M. J., Puy, R. M., & Weiner, J. M. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001186.pub2 · Cited by 497
Allergen immunotherapy for asthma
Abramson, M. J., Puy, R. M., & Weiner, J. M. (2003) · The Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001186 · Cited by 421
Standards for practical allergen‐specific immunotherapy
Alvarez‐Cuesta, E., Bousquet, J., Canonica, G. W., Durham, S. R., Malling, H. ‐., & Valovirta, E. (2006) · Allergy · doi:10.1111/j.1398-9995.2006.01219_1.x · Cited by 402
Self-citationNoninjection routes for immunotherapy
Canonica, G. W., & Passalacqua, G. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.129 · Cited by 283
Self-citation
Metadata
- Authors
- GIOVANE, A. L., BARDARE, M., PASSALACQUA, G., RUFFONI, S., SCORDAMAGLIA, A., GHEZZI, E., & CANONICA, G. W.
- Venue
- Clinical & Experimental Allergy
- Publisher
- Wiley
- Published
- 1994-01
- Volume
- 24
- Issue
- 1
- Pages
- 53-59
- ISSN
- 0954-7894 (ISSN-L)
- 1365-2222
- OpenAlex
- W2025968022
- Cited by
- 102
- References
- 1
- FWCI
- 1.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A three‐year double‐blind placebo‐controlled study with specific oral immunotherapy to Dermatophagoides: evidence of safety and efficacy in paediatric patients. https://app.cochat.ai/papers/10.1111/j.1365-2222.1994.tb00917.x
- The paper
- GIOVANE, A. L., BARDARE, M., PASSALACQUA, G., RUFFONI, S., SCORDAMAGLIA, A., GHEZZI, E., & CANONICA, G. W. (1994). A three‐year double‐blind placebo‐controlled study with specific oral immunotherapy to Dermatophagoides: evidence of safety and efficacy in paediatric patients. Clinical & Experimental Allergy. https://doi.org/10.1111/j.1365-2222.1994.tb00917.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.